Because the signal originates at the receptor level, it bypasses hypothalamic and pituitary regulatory layers
Rather than using the full therapeutic dose thats prescribed for active weight loss or blood sugar control, micro-dosing involves using smaller, less frequent doses of GLP-1 medications to maintain the metabolic benefits
The tradeoff is that higher doses require substantial volumes, and a full 2.4mg maintenance dose would require nearly 1.44ml, which exceeds the capacity of a standard 1ml insulin syringe
Tirzepatide: Dual GIP/GLP-1 Receptor Agonist Tirzepatide activates two receptor types simultaneously: GLP-1: Same appetite suppression and insulin-stimulating benefits as semaglutide GIP (Glucose-dependent insulinotropic polypeptide): Improves insulin sensitivity, influences fat metabolism, and may change how the body responds to nutrient intake GIP receptor activation is what sets tirzepatide apart
Plant Power: Why Pea Protein Outshines Dairy for GLP-1 Users The notion that plant proteins are inferior is outdated